demonstrated in numerous tumor cell lines that the trafficking of both wild-type and mutant p53 was granted by a functional microtubule network since cell treatment with microtubule-disrupting agents, vincristine, and taxol, drastically reduced nuclear accumulation of p53 [132]. This evidence concerns the gene TP53 and neoplasm.